1300018I emory university; vteu; to: 14-0094.B1C1D1.0024, protocol development, implementation and research lab assays for a a phase I trial to utilize systems biology approaches to examine the…

Ended Awarded Last action

Contract number
HHSN27200006
Awardee
Awarding agency
Obligated
$5,025,058

Award facts

Opportunity
Contract value 100% obligated
$5,025,057.70 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Atlanta, GA 30322, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00008 · To DE-obligate remaining funds and administratively close the task order. -$3,119
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $553,059
Supplemental Agreement for work within scope 4 $49,650
Exercise an Option 3 · 1300018I vteu a phase I trial to utilize systems biology approaches to examine the safety, immunogenicity, and `omics response to MVA-multi filo and AD26… $327,462
Other Administrative Action 2 · 1300018I to extend the period of performance of task area D-option 4, line item 5, from july 1, 2015 through august 15, 2016 to july 1, 2015 through december… $0
Other Administrative Action 1 · 1300018I this modification is to extend the period of performance of the base from july 1, 2015 through february 14, 2016 to july 1, 2015 through june 14, 2016. $0
Original award $4,098,006

About this award

Written by GovTribe AI ·

This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, with a ceiling value of $5,025,057.70, is for the development, implementation, and research of laboratory assays for a Phase I clinical trial to examine the safety, immunogenicity, and 'omics response to MVA-multi filo and AD26 Zaire vaccines in healthy volunteers. This contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, a major NIAID initiative to support the development and evaluation of new vaccines and treatments for infectious diseases. The contract does not have a set-aside designation.

Description

As the agency reported it.

1300018I emory university; vteu; to: 14-0094.B1C1D1.0024, protocol development, implementation and research lab assays for a a phase I trial to utilize systems biology approaches to examine the safety, immunogenicity, and `omics response to MVA-multi filo and AD26 zaire vaccines in healthy volunteers.

Quick answers

Who was awarded contract HHSN27200006?

HHSN27200006 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 22, 2015.

How much is contract HHSN27200006 worth?

The government has obligated $5,025,058 on HHSN27200006.

Is contract HHSN27200006 an order under another contract?

Yes. HHSN27200006 is a delivery order under HHSN272201300018I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200006 competed?

The extent of competition for HHSN27200006 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login